Why is President-elect Joe Biden a good pick for the pharma industry?
Former vice-president Joe Biden has defeated incumbent Donald Trump in the 2020 US Presidential election. A major battleground in the election was healthcare focused around response to the Covid-19 pandemic, reforms to the ACA and approaches to reduce drug prices in the US. Allie Nawrat explores why the pharma industry prefers Biden to his predecessor.